menu

Genetic testing to be centralised

This is seen as a positive development as it removes the potential reluctance to give a referral because of cost saving measures by the GP and Clinical Commissioning Group (CCG).  LPLD is included in the list of conditions to be tested for. National Genomic 2018/2019 Genetic Test Directory FAQs
View this article

Article: the burden of familial chylomicronaemia syndrome

Published in The Journal of Clinical Lipidology July-August 2018 this article gives the results of the global IN-FOCUS study showing how FCS affects patients.  You can read it here. https://www.lipidjournal.com/article/S1933-2874(18)30207f-1/pd
View this article

Article: Guidelines to diagnose FCS

Published in Athersclerosis, and available online in June 2018:  Identification and diagnosis of patients with familial chylomicronemia syndrome (FCS):  Expert panel recommendations and a proposal of an ‘FCS score’.  Read it here https://www.atherosclerosis-journal.com/article/S0021-9150(18)31126-2/fulltext
View this article

Article: Dietary recommendations

Published in the Journal of Clinical Lipidology (April 2018) this article ‘Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span’ reports on best practices and develops comprehensive dietary guidelines for nutrition therapy in patients with FCS. Read it here https://www.lipidjournal.com/article/S1933-2874(18)30208-3/fulltext
View this article
News archive